
pmid: 23127678
Overdoses involving prescription drugs in the United States have reached epidemic proportions over the past 20 years.This review categorizes and summarizes literature on the topic dating from the first published reports through 2011 using a traditional epidemiologic model of host, agent, and environment.Host factors include male sex, middle age, non-Hispanic white race, low income, and mental health problems. Agent risk factors include use of opioid analgesics and benzodiazepines, high prescribed dosage for opioid analgesics, multiple prescriptions, and multiple prescribers. Environmental factors include rural residence and high community prescribing rates.The epidemiology of prescription drug overdoses differs from the epidemiology of illicit drug overdoses. Incomplete understanding of prescription overdoses impedes prevention efforts.This epidemic demands additional attention from injury professionals.
Male, Rural Population, Prescription Drugs, Middle Aged, Drug Prescriptions, United States, Analgesics, Opioid, Risk Factors, Income, Humans, Drug Overdose
Male, Rural Population, Prescription Drugs, Middle Aged, Drug Prescriptions, United States, Analgesics, Opioid, Risk Factors, Income, Humans, Drug Overdose
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 216 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
